Navidea Provides Corporate Update and Reports Full Year 2016 Results

Mar 29, 2017

Navidea Completes Sale of North American Rights of Lymphoseek® to Cardinal Health

Mar 3, 2017

Navidea to Hold Conference Call to Provide Investor Update on Status of Ongoing Corporate Events

Jan 27, 2017

Navidea to Present at Upcoming Investor Conference

Jan 6, 2017

Navidea Signs Asset Purchase Agreement with Cardinal Health

Nov 23, 2016

Navidea Reports 2016 Third Quarter Financial Results

Nov 3, 2016

Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016

Oct 27, 2016

Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer

Sep 26, 2016

Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones

Sep 22, 2016

Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial

Sep 16, 2016